GlassScriptPhysician profile
Ali Ayoub
NPI 1740656099
$4,210.87
in general payments reported to CMS, 2019-2025
20 companies · $856 in 2025
The $856 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.51 · 2021: $183 · 2022: $924 · 2023: $1,306 · 2024: $894 · 2025: $856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,055.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $676.53 | 2019-2023 | Supera |
| Abiomed | $651.05 | 2022-2025 | Impella |
| Medtronic, INC. | $546.37 | 2022-2025 | Hawkone |
| Shockwave Medical, INC | $444.36 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $311.10 | 2019-2025 | Avvigo Guidance System, Synergy, Farapulse |
| Stryker Corporation | $259.78 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Inari Medical, INC. | $212.44 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Philips North America LLC | $200.99 | 2022-2024 | (Az7) Lasers, (Ck4) Mcot |
| Biosense Webster, INC. | $134.70 | 2023-2025 | Carto 3 |
| Bard Peripheral Vascular, INC. | $123.89 | 2025 | Rotarexs 6 F X 135 Cm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $111.67 | 2023-2024 | Lifevest |
| Pfizer INC. | $108.38 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $100.32 | 2023-2024 | Xarelto |
| Penumbra, INC. | $98.43 | 2024 | Indigo System |
| Novartis Pharmaceuticals Corporation | $83.32 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $63.70 | 2022 | |
| Amgen INC. | $30.10 | 2024-2025 | Repatha, Repatha |
| Actelion Pharmaceuticals US, INC. | $21.56 | 2024 | Opsumit, Uptravi |
| Scpharmaceuticals INC. | $16.60 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $15.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Ayoub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.